nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Ageusia—Doxorubicin—testicular cancer	0.00608	0.00608	CcSEcCtD
Rimantadine—Rigors—Doxorubicin—testicular cancer	0.00604	0.00604	CcSEcCtD
Rimantadine—Hallucination—Ifosfamide—testicular cancer	0.00601	0.00601	CcSEcCtD
Rimantadine—Dysphagia—Etoposide—testicular cancer	0.00596	0.00596	CcSEcCtD
Rimantadine—Chills—Dactinomycin—testicular cancer	0.00592	0.00592	CcSEcCtD
Rimantadine—Bronchospasm—Etoposide—testicular cancer	0.00586	0.00586	CcSEcCtD
Rimantadine—Sweating increased—Etoposide—testicular cancer	0.00581	0.00581	CcSEcCtD
Rimantadine—Lacrimation increased—Epirubicin—testicular cancer	0.00578	0.00578	CcSEcCtD
Rimantadine—Dyspepsia—Chlorambucil—testicular cancer	0.00571	0.00571	CcSEcCtD
Rimantadine—Anorexia—Vinblastine—testicular cancer	0.00567	0.00567	CcSEcCtD
Rimantadine—Stomatitis—Cisplatin—testicular cancer	0.00565	0.00565	CcSEcCtD
Rimantadine—Decreased appetite—Chlorambucil—testicular cancer	0.00564	0.00564	CcSEcCtD
Rimantadine—Tinnitus—Ifosfamide—testicular cancer	0.00563	0.00563	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.0056	0.0056	CcSEcCtD
Rimantadine—Fatigue—Chlorambucil—testicular cancer	0.00559	0.00559	CcSEcCtD
Rimantadine—Atrioventricular block—Epirubicin—testicular cancer	0.00549	0.00549	CcSEcCtD
Rimantadine—Gait disturbance—Epirubicin—testicular cancer	0.00546	0.00546	CcSEcCtD
Rimantadine—Chills—Ifosfamide—testicular cancer	0.00542	0.00542	CcSEcCtD
Rimantadine—Cough—Bleomycin—testicular cancer	0.00537	0.00537	CcSEcCtD
Rimantadine—Lacrimation increased—Doxorubicin—testicular cancer	0.00535	0.00535	CcSEcCtD
Rimantadine—Feeling abnormal—Chlorambucil—testicular cancer	0.00535	0.00535	CcSEcCtD
Rimantadine—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00531	0.00531	CcSEcCtD
Rimantadine—Stomatitis—Etoposide—testicular cancer	0.00518	0.00518	CcSEcCtD
Rimantadine—Decreased appetite—Vinblastine—testicular cancer	0.00517	0.00517	CcSEcCtD
Rimantadine—Abdominal pain—Chlorambucil—testicular cancer	0.00513	0.00513	CcSEcCtD
Rimantadine—Constipation—Vinblastine—testicular cancer	0.00508	0.00508	CcSEcCtD
Rimantadine—Atrioventricular block—Doxorubicin—testicular cancer	0.00508	0.00508	CcSEcCtD
Rimantadine—Confusional state—Bleomycin—testicular cancer	0.00506	0.00506	CcSEcCtD
Rimantadine—Gait disturbance—Doxorubicin—testicular cancer	0.00505	0.00505	CcSEcCtD
Rimantadine—Feeling abnormal—Vinblastine—testicular cancer	0.0049	0.0049	CcSEcCtD
Rimantadine—Gastrointestinal pain—Vinblastine—testicular cancer	0.00486	0.00486	CcSEcCtD
Rimantadine—Tinnitus—Cisplatin—testicular cancer	0.00486	0.00486	CcSEcCtD
Rimantadine—Agitation—Ifosfamide—testicular cancer	0.00483	0.00483	CcSEcCtD
Rimantadine—Anorexia—Bleomycin—testicular cancer	0.00479	0.00479	CcSEcCtD
Rimantadine—Hypoaesthesia—Etoposide—testicular cancer	0.00475	0.00475	CcSEcCtD
Rimantadine—Abdominal pain—Vinblastine—testicular cancer	0.0047	0.0047	CcSEcCtD
Rimantadine—Asthenia—Chlorambucil—testicular cancer	0.00466	0.00466	CcSEcCtD
Rimantadine—Palpitations—Ifosfamide—testicular cancer	0.00465	0.00465	CcSEcCtD
Rimantadine—Mental disability—Epirubicin—testicular cancer	0.00462	0.00462	CcSEcCtD
Rimantadine—Cough—Ifosfamide—testicular cancer	0.00459	0.00459	CcSEcCtD
Rimantadine—Convulsion—Ifosfamide—testicular cancer	0.00456	0.00456	CcSEcCtD
Rimantadine—Hypertension—Ifosfamide—testicular cancer	0.00454	0.00454	CcSEcCtD
Rimantadine—Dyspnoea—Bleomycin—testicular cancer	0.00448	0.00448	CcSEcCtD
Rimantadine—Anorexia—Dactinomycin—testicular cancer	0.00446	0.00446	CcSEcCtD
Rimantadine—Diarrhoea—Chlorambucil—testicular cancer	0.00444	0.00444	CcSEcCtD
Rimantadine—Decreased appetite—Bleomycin—testicular cancer	0.00437	0.00437	CcSEcCtD
Rimantadine—Confusional state—Ifosfamide—testicular cancer	0.00433	0.00433	CcSEcCtD
Rimantadine—Eye pain—Epirubicin—testicular cancer	0.00428	0.00428	CcSEcCtD
Rimantadine—Chills—Etoposide—testicular cancer	0.00428	0.00428	CcSEcCtD
Rimantadine—Mental disability—Doxorubicin—testicular cancer	0.00428	0.00428	CcSEcCtD
Rimantadine—Asthenia—Vinblastine—testicular cancer	0.00427	0.00427	CcSEcCtD
Rimantadine—Tremor—Cisplatin—testicular cancer	0.00425	0.00425	CcSEcCtD
Rimantadine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00415	0.00415	CcSEcCtD
Rimantadine—Feeling abnormal—Bleomycin—testicular cancer	0.00414	0.00414	CcSEcCtD
Rimantadine—Vomiting—Chlorambucil—testicular cancer	0.00413	0.00413	CcSEcCtD
Rimantadine—Anorexia—Ifosfamide—testicular cancer	0.00409	0.00409	CcSEcCtD
Rimantadine—Decreased appetite—Dactinomycin—testicular cancer	0.00407	0.00407	CcSEcCtD
Rimantadine—Diarrhoea—Vinblastine—testicular cancer	0.00407	0.00407	CcSEcCtD
Rimantadine—Fatigue—Dactinomycin—testicular cancer	0.00404	0.00404	CcSEcCtD
Rimantadine—Eye pain—Doxorubicin—testicular cancer	0.00396	0.00396	CcSEcCtD
Rimantadine—Cardiac failure—Epirubicin—testicular cancer	0.00396	0.00396	CcSEcCtD
Rimantadine—Dizziness—Vinblastine—testicular cancer	0.00393	0.00393	CcSEcCtD
Rimantadine—Convulsion—Cisplatin—testicular cancer	0.00393	0.00393	CcSEcCtD
Rimantadine—Ataxia—Methotrexate—testicular cancer	0.00388	0.00388	CcSEcCtD
Rimantadine—Feeling abnormal—Dactinomycin—testicular cancer	0.00386	0.00386	CcSEcCtD
Rimantadine—Nausea—Chlorambucil—testicular cancer	0.00385	0.00385	CcSEcCtD
Rimantadine—Anxiety—Cisplatin—testicular cancer	0.00385	0.00385	CcSEcCtD
Rimantadine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00383	0.00383	CcSEcCtD
Rimantadine—Dyspnoea—Ifosfamide—testicular cancer	0.00383	0.00383	CcSEcCtD
Rimantadine—Somnolence—Ifosfamide—testicular cancer	0.00382	0.00382	CcSEcCtD
Rimantadine—Vomiting—Vinblastine—testicular cancer	0.00378	0.00378	CcSEcCtD
Rimantadine—Decreased appetite—Ifosfamide—testicular cancer	0.00373	0.00373	CcSEcCtD
Rimantadine—Headache—Vinblastine—testicular cancer	0.00372	0.00372	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00371	0.00371	CcSEcCtD
Rimantadine—Abdominal pain—Dactinomycin—testicular cancer	0.0037	0.0037	CcSEcCtD
Rimantadine—Fatigue—Ifosfamide—testicular cancer	0.0037	0.0037	CcSEcCtD
Rimantadine—Constipation—Ifosfamide—testicular cancer	0.00367	0.00367	CcSEcCtD
Rimantadine—Cardiac failure—Doxorubicin—testicular cancer	0.00367	0.00367	CcSEcCtD
Rimantadine—Loss of consciousness—Etoposide—testicular cancer	0.00365	0.00365	CcSEcCtD
Rimantadine—Ataxia—Epirubicin—testicular cancer	0.00364	0.00364	CcSEcCtD
Rimantadine—Cough—Etoposide—testicular cancer	0.00362	0.00362	CcSEcCtD
Rimantadine—Tachycardia—Cisplatin—testicular cancer	0.00361	0.00361	CcSEcCtD
Rimantadine—Asthenia—Bleomycin—testicular cancer	0.0036	0.0036	CcSEcCtD
Rimantadine—Convulsion—Etoposide—testicular cancer	0.0036	0.0036	CcSEcCtD
Rimantadine—Hypertension—Etoposide—testicular cancer	0.00359	0.00359	CcSEcCtD
Rimantadine—Hyperhidrosis—Cisplatin—testicular cancer	0.00358	0.00358	CcSEcCtD
Rimantadine—Feeling abnormal—Ifosfamide—testicular cancer	0.00354	0.00354	CcSEcCtD
Rimantadine—Nausea—Vinblastine—testicular cancer	0.00353	0.00353	CcSEcCtD
Rimantadine—Anorexia—Cisplatin—testicular cancer	0.00353	0.00353	CcSEcCtD
Rimantadine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00351	0.00351	CcSEcCtD
Rimantadine—Confusional state—Etoposide—testicular cancer	0.00342	0.00342	CcSEcCtD
Rimantadine—Abdominal pain—Ifosfamide—testicular cancer	0.00339	0.00339	CcSEcCtD
Rimantadine—Ataxia—Doxorubicin—testicular cancer	0.00336	0.00336	CcSEcCtD
Rimantadine—Asthenia—Dactinomycin—testicular cancer	0.00336	0.00336	CcSEcCtD
Rimantadine—Dysphagia—Epirubicin—testicular cancer	0.00334	0.00334	CcSEcCtD
Rimantadine—Tachycardia—Etoposide—testicular cancer	0.00331	0.00331	CcSEcCtD
Rimantadine—Dyspnoea—Cisplatin—testicular cancer	0.0033	0.0033	CcSEcCtD
Rimantadine—Hyperhidrosis—Etoposide—testicular cancer	0.00328	0.00328	CcSEcCtD
Rimantadine—Anorexia—Etoposide—testicular cancer	0.00323	0.00323	CcSEcCtD
Rimantadine—Decreased appetite—Cisplatin—testicular cancer	0.00322	0.00322	CcSEcCtD
Rimantadine—Diarrhoea—Dactinomycin—testicular cancer	0.0032	0.0032	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00319	0.00319	CcSEcCtD
Rimantadine—Vomiting—Bleomycin—testicular cancer	0.00319	0.00319	CcSEcCtD
Rimantadine—Depression—Methotrexate—testicular cancer	0.00317	0.00317	CcSEcCtD
Rimantadine—Rash—Bleomycin—testicular cancer	0.00317	0.00317	CcSEcCtD
Rimantadine—Dermatitis—Bleomycin—testicular cancer	0.00316	0.00316	CcSEcCtD
Rimantadine—Stomatitis—Methotrexate—testicular cancer	0.0031	0.0031	CcSEcCtD
Rimantadine—Dysphagia—Doxorubicin—testicular cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Pollakiuria—Epirubicin—testicular cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Asthenia—Ifosfamide—testicular cancer	0.00308	0.00308	CcSEcCtD
Rimantadine—Feeling abnormal—Cisplatin—testicular cancer	0.00305	0.00305	CcSEcCtD
Rimantadine—Dyspnoea—Etoposide—testicular cancer	0.00302	0.00302	CcSEcCtD
Rimantadine—Somnolence—Etoposide—testicular cancer	0.00301	0.00301	CcSEcCtD
Rimantadine—Nausea—Bleomycin—testicular cancer	0.00298	0.00298	CcSEcCtD
Rimantadine—Vomiting—Dactinomycin—testicular cancer	0.00298	0.00298	CcSEcCtD
Rimantadine—Rash—Dactinomycin—testicular cancer	0.00295	0.00295	CcSEcCtD
Rimantadine—Decreased appetite—Etoposide—testicular cancer	0.00295	0.00295	CcSEcCtD
Rimantadine—Diarrhoea—Ifosfamide—testicular cancer	0.00294	0.00294	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Etoposide—testicular cancer	0.00293	0.00293	CcSEcCtD
Rimantadine—Fatigue—Etoposide—testicular cancer	0.00292	0.00292	CcSEcCtD
Rimantadine—Stomatitis—Epirubicin—testicular cancer	0.0029	0.0029	CcSEcCtD
Rimantadine—Constipation—Etoposide—testicular cancer	0.0029	0.0029	CcSEcCtD
Rimantadine—Pollakiuria—Doxorubicin—testicular cancer	0.00286	0.00286	CcSEcCtD
Rimantadine—Dizziness—Ifosfamide—testicular cancer	0.00284	0.00284	CcSEcCtD
Rimantadine—Feeling abnormal—Etoposide—testicular cancer	0.00279	0.00279	CcSEcCtD
Rimantadine—Nausea—Dactinomycin—testicular cancer	0.00278	0.00278	CcSEcCtD
Rimantadine—Gastrointestinal pain—Etoposide—testicular cancer	0.00277	0.00277	CcSEcCtD
Rimantadine—Vomiting—Ifosfamide—testicular cancer	0.00273	0.00273	CcSEcCtD
Rimantadine—Rash—Ifosfamide—testicular cancer	0.00271	0.00271	CcSEcCtD
Rimantadine—Dermatitis—Ifosfamide—testicular cancer	0.0027	0.0027	CcSEcCtD
Rimantadine—Stomatitis—Doxorubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Rimantadine—Abdominal pain—Etoposide—testicular cancer	0.00268	0.00268	CcSEcCtD
Rimantadine—Tinnitus—Methotrexate—testicular cancer	0.00266	0.00266	CcSEcCtD
Rimantadine—Hypoaesthesia—Epirubicin—testicular cancer	0.00266	0.00266	CcSEcCtD
Rimantadine—Asthenia—Cisplatin—testicular cancer	0.00265	0.00265	CcSEcCtD
Rimantadine—Oedema peripheral—Epirubicin—testicular cancer	0.00263	0.00263	CcSEcCtD
Rimantadine—Chills—Methotrexate—testicular cancer	0.00256	0.00256	CcSEcCtD
Rimantadine—Nausea—Ifosfamide—testicular cancer	0.00255	0.00255	CcSEcCtD
Rimantadine—Diarrhoea—Cisplatin—testicular cancer	0.00253	0.00253	CcSEcCtD
Rimantadine—Tinnitus—Epirubicin—testicular cancer	0.00249	0.00249	CcSEcCtD
Rimantadine—Hypoaesthesia—Doxorubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Rimantadine—Oedema peripheral—Doxorubicin—testicular cancer	0.00244	0.00244	CcSEcCtD
Rimantadine—Asthenia—Etoposide—testicular cancer	0.00243	0.00243	CcSEcCtD
Rimantadine—Chills—Epirubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Rimantadine—Vomiting—Cisplatin—testicular cancer	0.00235	0.00235	CcSEcCtD
Rimantadine—Rash—Cisplatin—testicular cancer	0.00233	0.00233	CcSEcCtD
Rimantadine—Dermatitis—Cisplatin—testicular cancer	0.00233	0.00233	CcSEcCtD
Rimantadine—Diarrhoea—Etoposide—testicular cancer	0.00232	0.00232	CcSEcCtD
Rimantadine—Tinnitus—Doxorubicin—testicular cancer	0.00231	0.00231	CcSEcCtD
Rimantadine—Tension—Epirubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Rimantadine—Nervousness—Epirubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Rimantadine—Dizziness—Etoposide—testicular cancer	0.00224	0.00224	CcSEcCtD
Rimantadine—Chills—Doxorubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Rimantadine—Nausea—Cisplatin—testicular cancer	0.0022	0.0022	CcSEcCtD
Rimantadine—Cough—Methotrexate—testicular cancer	0.00217	0.00217	CcSEcCtD
Rimantadine—Convulsion—Methotrexate—testicular cancer	0.00216	0.00216	CcSEcCtD
Rimantadine—Vomiting—Etoposide—testicular cancer	0.00216	0.00216	CcSEcCtD
Rimantadine—Agitation—Epirubicin—testicular cancer	0.00214	0.00214	CcSEcCtD
Rimantadine—Rash—Etoposide—testicular cancer	0.00214	0.00214	CcSEcCtD
Rimantadine—Dermatitis—Etoposide—testicular cancer	0.00214	0.00214	CcSEcCtD
Rimantadine—Headache—Etoposide—testicular cancer	0.00212	0.00212	CcSEcCtD
Rimantadine—Tension—Doxorubicin—testicular cancer	0.00211	0.00211	CcSEcCtD
Rimantadine—Nervousness—Doxorubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Rimantadine—Syncope—Epirubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Rimantadine—Palpitations—Epirubicin—testicular cancer	0.00206	0.00206	CcSEcCtD
Rimantadine—Confusional state—Methotrexate—testicular cancer	0.00205	0.00205	CcSEcCtD
Rimantadine—Loss of consciousness—Epirubicin—testicular cancer	0.00205	0.00205	CcSEcCtD
Rimantadine—Cough—Epirubicin—testicular cancer	0.00203	0.00203	CcSEcCtD
Rimantadine—Convulsion—Epirubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Rimantadine—Nausea—Etoposide—testicular cancer	0.00201	0.00201	CcSEcCtD
Rimantadine—Hypertension—Epirubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Rimantadine—Agitation—Doxorubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Rimantadine—Anxiety—Epirubicin—testicular cancer	0.00198	0.00198	CcSEcCtD
Rimantadine—Hyperhidrosis—Methotrexate—testicular cancer	0.00196	0.00196	CcSEcCtD
Rimantadine—Dry mouth—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Rimantadine—Anorexia—Methotrexate—testicular cancer	0.00194	0.00194	CcSEcCtD
Rimantadine—Syncope—Doxorubicin—testicular cancer	0.00193	0.00193	CcSEcCtD
Rimantadine—Confusional state—Epirubicin—testicular cancer	0.00192	0.00192	CcSEcCtD
Rimantadine—Palpitations—Doxorubicin—testicular cancer	0.0019	0.0019	CcSEcCtD
Rimantadine—Loss of consciousness—Doxorubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Rimantadine—Cough—Doxorubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Rimantadine—Shock—Epirubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Rimantadine—Convulsion—Doxorubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Rimantadine—Hypertension—Doxorubicin—testicular cancer	0.00186	0.00186	CcSEcCtD
Rimantadine—Tachycardia—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Rimantadine—Hyperhidrosis—Epirubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Rimantadine—Insomnia—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Rimantadine—Anxiety—Doxorubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Rimantadine—Anorexia—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Rimantadine—Dyspnoea—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Rimantadine—Somnolence—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Rimantadine—Dry mouth—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Rimantadine—Dyspepsia—Methotrexate—testicular cancer	0.00179	0.00179	CcSEcCtD
Rimantadine—Confusional state—Doxorubicin—testicular cancer	0.00177	0.00177	CcSEcCtD
Rimantadine—Decreased appetite—Methotrexate—testicular cancer	0.00177	0.00177	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Rimantadine—Fatigue—Methotrexate—testicular cancer	0.00175	0.00175	CcSEcCtD
Rimantadine—Shock—Doxorubicin—testicular cancer	0.00173	0.00173	CcSEcCtD
Rimantadine—Insomnia—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Rimantadine—Tachycardia—Doxorubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Rimantadine—Hyperhidrosis—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Rimantadine—Dyspnoea—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Rimantadine—Somnolence—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Rimantadine—Anorexia—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Rimantadine—Feeling abnormal—Methotrexate—testicular cancer	0.00167	0.00167	CcSEcCtD
Rimantadine—Dyspepsia—Epirubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Rimantadine—Gastrointestinal pain—Methotrexate—testicular cancer	0.00166	0.00166	CcSEcCtD
Rimantadine—Decreased appetite—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Rimantadine—Fatigue—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Rimantadine—Constipation—Epirubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Rimantadine—Abdominal pain—Methotrexate—testicular cancer	0.00161	0.00161	CcSEcCtD
Rimantadine—Insomnia—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Rimantadine—Dyspnoea—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Rimantadine—Feeling abnormal—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Rimantadine—Somnolence—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Rimantadine—Gastrointestinal pain—Epirubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Rimantadine—Dyspepsia—Doxorubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Rimantadine—Decreased appetite—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Rimantadine—Fatigue—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Rimantadine—Constipation—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Rimantadine—Abdominal pain—Epirubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Rimantadine—Asthenia—Methotrexate—testicular cancer	0.00146	0.00146	CcSEcCtD
Rimantadine—Feeling abnormal—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Rimantadine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Rimantadine—Abdominal pain—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Rimantadine—Diarrhoea—Methotrexate—testicular cancer	0.00139	0.00139	CcSEcCtD
Rimantadine—Asthenia—Epirubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Rimantadine—Dizziness—Methotrexate—testicular cancer	0.00134	0.00134	CcSEcCtD
Rimantadine—Diarrhoea—Epirubicin—testicular cancer	0.0013	0.0013	CcSEcCtD
Rimantadine—Vomiting—Methotrexate—testicular cancer	0.00129	0.00129	CcSEcCtD
Rimantadine—Rash—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Rimantadine—Dermatitis—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Rimantadine—Headache—Methotrexate—testicular cancer	0.00127	0.00127	CcSEcCtD
Rimantadine—Asthenia—Doxorubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Rimantadine—Dizziness—Epirubicin—testicular cancer	0.00126	0.00126	CcSEcCtD
Rimantadine—Vomiting—Epirubicin—testicular cancer	0.00121	0.00121	CcSEcCtD
Rimantadine—Nausea—Methotrexate—testicular cancer	0.00121	0.00121	CcSEcCtD
Rimantadine—Diarrhoea—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Rimantadine—Rash—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Rimantadine—Dermatitis—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Rimantadine—Headache—Epirubicin—testicular cancer	0.00119	0.00119	CcSEcCtD
Rimantadine—Dizziness—Doxorubicin—testicular cancer	0.00116	0.00116	CcSEcCtD
Rimantadine—Nausea—Epirubicin—testicular cancer	0.00113	0.00113	CcSEcCtD
Rimantadine—Vomiting—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Rimantadine—Rash—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Rimantadine—Dermatitis—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Rimantadine—Headache—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Rimantadine—Nausea—Doxorubicin—testicular cancer	0.00104	0.00104	CcSEcCtD
